Glutamatergic Dysfunction in Schizophrenia Evaluated With Magnetic Resonance Spectroscopy
Authors:
- 1 July 2016
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 73 (7) , 649-650
Abstract
Positron emission tomography has been the dominant method for probing the neurochemistry of psychiatric disorders in living humans. This bias reflects the widelKeywords
This publication has 6 references indexed in Scilit:
- The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyondCurrent Opinion in Pharmacology, 2015
- In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophreniaNeurobiology of Disease, 2015
- Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapySchizophrenia Research, 2015
- Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brainPsychopharmacology, 2013
- 13C MRS studies of neuroenergetics and neurotransmitter cycling in humansNMR in Biomedicine, 2011
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008